RenovoRx Inc (NASDAQ:RNXT)’s traded shares stood at 0.35 million during the last session, with the company’s beta value hitting 1.09. At the close of trading, the stock’s price was $1.50, to imply an increase of 6.38% or $0.09 in intraday trading. The RNXT share’s 52-week high remains $1.86, putting it -24.0% down since that peak but still an impressive 48.67% since price per share fell to its 52-week low of $0.77. The company has a valuation of $36.00M, with an average of 0.11 million shares in intraday trading volume over the past 10 days and average of 76.25K shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for RenovoRx Inc (RNXT), translating to a mean rating of 1.00. Of 3 analyst(s) looking at the stock, 0 analyst(s) give RNXT a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 3 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.12.
RenovoRx Inc (NASDAQ:RNXT) trade information
After registering a 6.38% upside in the last session, RenovoRx Inc (RNXT) has traded red over the past five days. The 5-day price performance for the stock is 12.78%, and 20.00% over 30 days. With these gigs, the year-to-date price performance is 16.28%. Short interest in RenovoRx Inc (NASDAQ:RNXT) saw shorts transact 71850.0 shares and set a 3.43 days time to cover.
RenovoRx Inc (RNXT) estimates and forecasts
Looking at statistics comparing RenovoRx Inc share performance against respective industry, we note that the company has outperformed competitors. RenovoRx Inc (RNXT) shares are 26.05% up over the last 6 months, with its year-to-date growth rate higher than industry average at 65.52% against 16.60%.
RNXT Dividends
RenovoRx Inc has its next earnings report out in February. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
RenovoRx Inc (NASDAQ:RNXT)’s Major holders
RenovoRx Inc insiders hold 1.90% of total outstanding shares, with institutional holders owning 8.18% of the shares at 8.34% float percentage. In total, 8.18% institutions holds shares in the company, led by ADAR1 CAPITAL MANAGEMENT, LLC. As of 2024-06-30, the company held over 0.36 million shares (or 2.3766% of shares), all amounting to roughly $0.4 million.
The next major institution holding the largest number of shares is GEODE CAPITAL MANAGEMENT, LLC with 0.14 million shares, or about 0.9628% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $0.16 million.
We also have Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the RenovoRx Inc (RNXT) shares. Going by data provided on Nov 30, 2024 , Fidelity Extended Market Index Fund holds roughly 136.5 shares. This is just over 0.57% of the total shares, with a market valuation of $0.2 million. Data from the same date shows that the other fund manager holds a little less at 56.74, or 0.24% of the shares, all valued at about 85105.0.
